Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00GIR
|
|||
| Former ID |
DIB015244
|
|||
| Drug Name |
DAC-060
|
|||
| Synonyms |
DAC-0060; DAC-60; HDAC inhibitor (topical, skin cancer/actinic keratosis), DAC
Click to Show/Hide
|
|||
| Indication | Keratosis [ICD-11: ED56; ICD-10: L57.0] | Phase 2 | [1] | |
| Company |
DAC Srl
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histone deacetylase (HDAC) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031213) | |||
| REF 2 | Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Correction in: volume 4 on page 1369. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.